ACA exchange exits leave more rural areas with one insurer

More rural regions than ever before will have only one insurer’s plans available to customers in the Affordable Care Act’s marketplaces for 2017, reported the Wall Street Journal.

According to data from the Kaiser Family Foundation tracking the exit of insurers from exchanges—like UnitedHealth and Humana—at least 650 counties are set to have only one insurer to choose from in 2017, up from 225 in 2016. Cynthia Cox, a researcher at the foundation, told the WSJ that around 455 of those counties would be considered rural.

Exchanges in Alabama, Alaska and Wyoming are set to have one insurer’s plans available statewide, according to state regulators, along with parts of Arizona, Kentucky, Mississippi, Oklahoma and Tennessee. It’s possible the number of single-insurer counties could change, because companies don’t have to finalize their approaches with regulators until September.

The departure from rural areas can largely be blamed on the cost for insurers to cover people in those parts of the country. An analysis by health technology firm Inovalon found monthly costs per plan member for insurers were significantly higher in smaller towns and cities. The average monthly cost for an individual living in a town with a population of between 2,500 and 10,000 was nearly $570, compared to $415 per month for a member living in a city of 50,000 people or more.

The limited choices for 2017 are a cause for concern for regulators.

“When there’s more competition, consumers typically are better off,” Mark Fowler, chief of staff at the Alabama Department of Insurance, told the WSJ.

Fowler confirmed Humana and UnitedHealth will be exiting the state’s marketplace in 2017, leaving only plans from Blue Cross and Blue Shield of Alabama.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.